SAIC / Science Applications International Corporation - SEC-Einreichungen, Jahresbericht, Proxy Statement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2026 Science Applications

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2026 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp

Three Months Ended May 1, 2026 Percent change May 2, 2025 (dollars in millions, except per share amounts) Revenues $ 1,906 2 % $ 1,877 Operating income 179 48 % 121 Operating income as a percentage of revenues 9.4 % 300bps 6.4 % Adjusted operating in

Exhibit 99.1 SAIC Announces First Quarter of Fiscal Year 2027 Results •Revenues of $1.91 billion, approximately 2% growth; 0.5% organic growth(1) adjusted for SilverEdge acquisition •Net bookings of $2.1 billion; quarterly book-to-bill ratio of 1.1; trailing twelve months book-to-bill ratio of 1.0 •Net income of $115 million; Adjusted EBITDA(1) of $222 million or 11.6% of revenues •Diluted earning

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2026 Science Applications

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2026 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of incorp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 1, 2026 ☐ TRANSITION REPORT PURS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 1, 2026 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science Appli

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2026 Science Applications

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2026 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2025 to December 31, 2025

Exhibit 1.01 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2025 to December 31, 2025 This Conflict Minerals Report (this “Report”) of Science Applications International Corporation (herein referred to as the “Company,” “we,” “us,” or “our”), has been prepared pursuant to Rule 13p-1 (the “Rule”) and Form SD promulgated under the Sec

SAIC Board of Directors Declares Cash Dividend

Exhibit 99.1 SAIC Board of Directors Declares Cash Dividend RESTON, Va., May 29, 2026 – Science Applications International Corp. (NASDAQ: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on July 24, 2026 to stockholders of record on July 10, 2026. SAIC intends to continue paying dividends on a quarterly ba

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of the Registrant as Specified in Its Charter) Delaware 001- 35832 461932921 (Sta

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of the Registrant as Specified in Its Charter) Delaware 001- 35832 461932921 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 12010 Sunset Hills Road, Reston, Virginia 201

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☒ Definitive Additional Materials ☐ Soliciting Material Pursuant to § 240.

DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐Preliminary Proxy Statement ☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒Definitive Proxy Statement ☐Definitive Additional Materials ☐Soliciting Material Pursuant to § 240.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 7, 2026

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 7, 2026 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other j

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 7, 2026 Science Application

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 7, 2026 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of incor

California

Exhibit 21 Subsidiaries of Registrant Jurisdiction of Incorporation or Organization SAIC International Holdings, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 30, 2026 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-35832 Science Applicat

(dollars in millions, except per share amounts)

Exhibit 99.1 SAIC Announces Fourth Quarter and Full Fiscal Year 2026 Results •Q4 FY26 revenues of $1.75 billion; FY26 revenues of $7.26 billion •Q4 FY26 net income of $85 million, adjusted EBITDA(1) of $181 million or 10.3% of revenue; FY26 net income of $358 million, adjusted EBITDA(1) of $708 million or 9.7% of revenue •Q4 FY26 diluted earnings per share of $1.87, adjusted diluted earnings per s

Calculation of Filing Fee Tables Form S-8 Science Applications International Corporation Table 1: Newly Registered Securities

Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 Science Applications International Corporation Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price (2) Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.0001 per share Rule 457(c) and

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2026 Science Applicatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2026 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco

As filed with the Securities and Exchange Commission on March 16, 2026 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-8 REGISTRATION STATEMENT THE SECURITIES ACT OF 1933 Science Applications Inter

As filed with the Securities and Exchange Commission on March 16, 2026 Registration No.

12010 Sunset Hills Rd, Reston VA 20190 703.676.4300 | saic.com 1 February 18, 2026 James C. Reagan Delivered via electronic communication Dear Jim: On behalf of Science Applications International Corporation (SAIC) and our Board of Directors, I am de

saicfy2610-kex101 12010 Sunset Hills Rd, Reston VA 20190 703.676.4300 | saic.com 1 February 18, 2026 James C. Reagan Delivered via electronic communication Dear Jim: On behalf of Science Applications International Corporation (SAIC) and our Board of Directors, I am delighted to extend you an offer to take on the permanent role of Chief Executive Officer (CEO), transitioning from your current posit

SAIC Board of Directors Declares Cash Dividend

Exhibit 99.1 SAIC Board of Directors Declares Cash Dividend RESTON, Va., Mar. 13, 2026 – Science Applications International Corp. (NASDAQ: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on April 24, 2026 to stockholders of record on April 10, 2026. SAIC intends to continue paying dividends on a quarterly

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2026 Science Applicatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2026 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco

SAIC Announces CEO Appointment

EX-99.1 Exhibit 99.1 SAIC Announces CEO Appointment February 17, 2026 Interim CEO, Former Board Member, and Seasoned Government Services Executive James Reagan Named CEO Reston, Va., Feb. 17, 2026 (GLOBE NEWSWIRE) Science Applications International Corporation (Nasdaq: SAIC), a premier Fortune 500® company driving our nation’s digital transformation across the defense, space, civilian, and intelli

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2026 Science Applica

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2026 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of i

Three Months Ended October 31, 2025 Percent change November 1, 2024 (dollars in millions, except per share amounts) Revenues $ 1,866 (6) % $ 1,976 Operating income 128 (20) % 160 Operating income as a percentage of revenues 6.9 % -120bps 8.1 % Adjust

Exhibit 99.1 SAIC Announces Third Quarter of Fiscal Year 2026 Results •Revenues of $1.87 billion •Net bookings of $2.2 billion; book-to-bill ratio and trailing twelve months book-to-bill ratio of 1.2 •Year-to-date net bookings of $7.2 billion; year-to-date book-to-bill ratio of 1.3 •Net income of $78 million; Adjusted EBITDA(1) of $185 million or 9.9% of revenues •Diluted earnings per share of $1.

OFFER LETTER

saic1031202510-qex103

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2025 Science Applicat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of In

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2025 ☐ TRANSITION REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science

EXECUTIVE SEVERANCE, CHANGE IN CONTROL AND RETIREMENT POLICY

saic1031202510-qex102

SAIC ANNOUNCES ORGANIZATIONAL CHANGES INTENDED TO SIMPLIFY STRUCTURE, SHARPEN FOCUS AND DELIVER SUSTAINABLE LONG-TERM GROWTH AND SHAREHOLDER VALUE CREATION

EX-99.1 Exhibit 99.1 SAIC ANNOUNCES ORGANIZATIONAL CHANGES INTENDED TO SIMPLIFY STRUCTURE, SHARPEN FOCUS AND DELIVER SUSTAINABLE LONG-TERM GROWTH AND SHAREHOLDER VALUE CREATION Highlights: • Five existing business groups will be consolidated into three business groups • The consolidated business groups are Army Navy (ANG); Air Force, Space and Intelligence (AFSI); and Civilian • The restructured o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2025 Science Applica

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of i

SAIC Announces CEO Transition SAIC Director and Seasoned Government Services Executive James Reagan Appointed Interim CEO Company Reaffirms Fiscal Year 2026 Guidance

EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE SAIC Announces CEO Transition SAIC Director and Seasoned Government Services Executive James Reagan Appointed Interim CEO Company Reaffirms Fiscal Year 2026 Guidance RESTON, Va., October 23, 2025 – Science Applications International Corporation (Nasdaq: SAIC), a premier Fortune 500® company driving our nation’s digital transformation across the defense, s

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 23, 2025 Science Applicat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 23, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of in

SAIC to Acquire SilverEdge Government Solutions Move bolsters SAIC’s leading role of bringing commercial-grade technologies and solutions to advance national security missions and operations

Exhibit 99.1 SAIC to Acquire SilverEdge Government Solutions Move bolsters SAIC’s leading role of bringing commercial-grade technologies and solutions to advance national security missions and operations RESTON, Va., October 6, 2025 – Science Applications International Corp. (NASDAQ: SAIC), a leading mission integrator supporting defense, space, intelligence and civilian agencies, announced today

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 6, 2025 Science Applicati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 6, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inc

2 [[8017017]] accrued and unpaid interest thereon, (c) pay fees and expenses in connection with the transactions contemplated by this Agreement and (d) to the extent any proceeds remain after application in accordance with the foregoing clauses (a),

saic8k09302025exhibit101 2 [[8017017]] accrued and unpaid interest thereon, (c) pay fees and expenses in connection with the transactions contemplated by this Agreement and (d) to the extent any proceeds remain after application in accordance with the foregoing clauses (a), (b) and (c), fund cash to the balance sheet of the Borrower; WHEREAS, the Borrower, the Administrative Agent, each Person tha

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2025 Science Applic

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of

Exhibit 4.1 EXECUTION VERSION SCIENCE APPLICATIONS INTERNATIONAL CORPORATION, as Issuer INDENTURE Dated as of September 25, 2025 U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee $500,000,000 5.875% Senior Notes due 2033 i TABLE OF CONTENTS A

saic8k09252025exhibit41 Exhibit 4.1 EXECUTION VERSION SCIENCE APPLICATIONS INTERNATIONAL CORPORATION, as Issuer INDENTURE Dated as of September 25, 2025 U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee $500,000,000 5.875% Senior Notes due 2033 i TABLE OF CONTENTS ARTICLE I Definitions and Incorporation by Reference ....................................................................... 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2025 Science Applic

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of

SAIC Announces Pricing of $500.0 Million in Senior Notes

Exhibit 99.1 SAIC Announces Pricing of $500.0 Million in Senior Notes RESTON, Va., Sept. 22, 2025 – Science Applications International Corp. (NASDAQ: SAIC) (“SAIC”), a premier Fortune 500 technology integrator driving our nation's digital transformation across the defense, space, civilian, and intelligence markets, announced today that it has priced an offering of $500.0 million aggregate principa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2025 Science Applic

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of

SAIC Announces Proposed Offering of $500.0 Million in Senior Notes

Exhibit 99.1 SAIC Announces Proposed Offering of $500.0 Million in Senior Notes RESTON, Va., Sept. 22, 2025 – Science Applications International Corp. (NASDAQ: SAIC) (“SAIC”), a premier Fortune 500 technology integrator driving our nation's digital transformation across the defense, space, civilian, and intelligence markets, announced today that it intends to commence an offering of $500.0 million

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2025 Science Applic

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 22, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of

LETTER

September 9, 2025 Prabu Natarajan Chief Financial Officer Science Applications International Corporation 12010 Sunset Hills Road Reston, VA 20190 Re: Science Applications International Corporation Form 10-K for Fiscal Year Ended January 31, 2025 File No.

Three Months Ended August 1, 2025 Percent change August 2, 2024 (dollars in millions, except per share amounts) Revenues $ 1,769 (3)% $ 1,818 Operating income 139 4% 134 Operating income as a percentage of revenues 7.9 % 50bps 7.4 % Adjusted operatin

Exhibit 99.1 SAIC Announces Second Quarter of Fiscal Year 2026 Results •Revenues of $1.77 billion; approximately (3)% revenue contraction •Net bookings of $2.6 billion; book-to-bill ratio of 1.5, trailing twelve months book-to-bill ratio of 1.0 •Year-to-date net bookings of $5.0 billion; year-to-date book-to-bill ratio of 1.4 •Net income of $127 million; Adjusted EBITDA(1) of $185 million or 10.5%

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 4, 2025 Science Applica

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 4, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 1, 2025 ☐ TRANSITION REPORT P

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 1, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science Ap

September 03, 2025

12010 Sunset Hills Road Reston, VA 20190 703.676.4300 | saic.com Prabu Natarajan Chief Financial Officer September 03, 2025 Joyce Sweeney U.S. Securities and Exchange Commission | Division of Corporation Finance 100 F Street, NE | Washington, DC 20549 Re: Science Applications International Corporation Form 10-K for the Fiscal Year Ended January 31, 2025 Filed March 17, 2025 File No. 001-35832 Dear

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2025 Science Applicati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inc

SAIC Board of Directors Declares Cash Dividend

Exhibit 99.1 SAIC Board of Directors Declares Cash Dividend RESTON, Va., Aug. 29, 2025 – Science Applications International Corp. (NASDAQ: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on October 24, 2025 to stockholders of record on October 10, 2025. SAIC intends to continue paying dividends on a quart

LETTER

August 27, 2025 Prabu Natarajan Chief Financial Officer Science Applications International Corporation 12010 Sunset Hills Road Reston, VA 20190 Re: Science Applications International Corporation Form 10-K for Fiscal Year Ended January 31, 2025 File No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2025 Science Application

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of incor

t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K

t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35832 A. Full title of plan and the address

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2025 Science Applications

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 2, 2025 ☐ TRANSITION REPORT PURS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 2, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science Appli

Three Months Ended May 2, 2025 Percent change May 3, 2024 (dollars in millions, except per share amounts) Revenues $ 1,877 2 % $ 1,847 Operating income 121 (8) % 131 Operating income as a percentage of revenues 6.4 % -70bps 7.1 % Adjusted operating i

Exhibit 99.1 SAIC Announces First Quarter of Fiscal Year 2026 Results •Revenues of $1.88 billion; approximately 2% revenue growth •Net bookings of $2.4 billion; book-to-bill ratio of 1.3 •Net income of $68 million; Adjusted EBITDA(1) of $157 million or 8.4% of revenues •Diluted earnings per share of $1.42; Adjusted diluted earnings per share(1) of $1.92 •Cash flows provided by operating activities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2025 Science Applications

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp

SAIC Board of Directors Declares Cash Dividend

Exhibit 99.1 SAIC Board of Directors Declares Cash Dividend RESTON, Va., May 30, 2025 – Science Applications International Corp. (NASDAQ: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on July 25, 2025 to stockholders of record on July 11, 2025. SAIC intends to continue paying dividends on a quarterly ba

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2024 to December 31, 2024

Exhibit 1.01 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2024 to December 31, 2024 This Conflict Minerals Report (this “Report”) of Science Applications International Corporation (herein referred to as the “Company,” “we,” “us,” or “our”), has been prepared pursuant to Rule 13p-1 (the “Rule”) and Form SD promulgated under the Sec

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of the Registrant as Specified in Its Charter) Delaware 001- 35832 461932921 (Sta

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of the Registrant as Specified in Its Charter) Delaware 001- 35832 461932921 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 12010 Sunset Hills Road, Reston, Virginia 201

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☒ Definitive Additional Materials ☐ Soliciting Material Pursuant to § 240.

DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐Preliminary Proxy Statement ☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒Definitive Proxy Statement ☐Definitive Additional Materials ☐Soliciting Material Pursuant to § 240.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco

Insider Trading Policies and Procedures.

SAIC INSTRUCTION SI-POL1-04 INSIDER TRADING COMPLIANCE AND DISCLOSURE SI-POL1-04 V1.

Subsidiaries of Registrant.

Exhibit 21 Subsidiaries of Registrant Jurisdiction of Incorporation or Organization SAIC International Holdings, Inc.

CURRENT Fiscal Year PRIOR Fiscal Year 2026 Guidance 2026 Targets Revenue $7.60B - $7.75B $7.55B - $7.75B Adjusted EBITDA(1) $715M - $735M ~$720M Adjusted EBITDA Margin %(1) 9.4% - 9.6% 9.3% - 9.5% Adjusted Diluted EPS(1) $9.10 - $9.30 $8.90 - $9.10 F

Exhibit 99.1 SAIC Announces Fourth Quarter and Full Fiscal Year 2025 Results •Q4 FY25 revenues of $1.84 billion, 5.8% organic growth(1); FY25 revenues of $7.48 billion, 3.1% organic growth(1); organic growth adjusted for divestitures •Q4 FY25 net income of $98 million, adjusted EBITDA(1) of $177 million or 9.6% of revenue; FY25 net income of $362 million, adjusted EBITDA(1) of $710 million or 9.5%

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-35832 Science Applicat

SAIC Board of Directors Declares Cash Dividend

Exhibit 99.1 SAIC Board of Directors Declares Cash Dividend Reston, Va., Mar. 14, 2025 – Science Applications International Corp. (NASDAQ: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on April 25, 2025 to stockholders of record on April 11, 2025. SAIC intends to continue paying dividends on a quarterly

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2025 Science Applicatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco

JOINT FILING AGREEMENT

JOINT FILING AGREEMENT The undersigned hereby agree that this Schedule 13G (the “Schedule 13G”) with respect to the common stock of Science Applications International Corporation is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements.

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 2, 2025 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of inc

Three Months Ended November 1, 2024 Percent change November 3, 2023 (in millions, except per share amounts) Revenues $ 1,976 4 % $ 1,895 Operating income 160 12 % 143 Operating income as a percentage of revenues 8.1 % 60 bps 7.5 % Adjusted operating

Exhibit 99.1 SAIC Announces Third Quarter of Fiscal Year 2025 Results •Revenues of $1.98 billion; 4.3% revenue growth •Net income of $106 million; Adjusted EBITDA(1) of $197 million or 10.0% of revenues •Diluted earnings per share of $2.13; Adjusted diluted earnings per share(1) of $2.61 •Cash flows provided by operating activities of $143 million; free cash flow(1) of $9 million •Net bookings of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 1, 2024 ☐ TRANSITION REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 1, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of In

SAIC Board of Directors Declares Cash Dividend

Exhibit 99.1 SAIC Board of Directors Declares Cash Dividend Reston, Va., Dec. 04, 2024 – Science Applications International Corp. (NASDAQ: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on January 24, 2025 to stockholders of record on January 10, 2025. SAIC intends to continue paying dividends on a quart

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of In

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of i

SAIC / Science Applications International Corporation / Boston Partners - BOSTON PARTNERS Passive Investment

SC 13G/A 1 saica5111424.htm BOSTON PARTNERS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of in

SAIC / Science Applications International Corporation / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6 )* Science Applications International Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement)

JOINT FILING AGREEMENT

JOINT FILING AGREEMENT The undersigned hereby agree that this Schedule 13G (the “Schedule 13G”) with respect to the common stock of Science Applications International Corporation is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements.

, by and among SAIC, Citibank N.A., as administrative agent and collateral agent, and certain other lenders and parties thereto. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on

Exhibit 10.1 Execution Version AMERICAS/2024344424.6 SEVENTH AMENDMENT This SEVENTH AMENDMENT, dated as of October 18, 2024 (this “Agreement”), to the THIRD AMENDED AND RESTATED CREDIT AGREEMENT dated as of October 31, 2018 (as amended by that certain FIRST AMENDMENT, dated as of February 19, 2020, that certain SECOND AMENDMENT, dated as of March 13, 2020, that certain THIRD AMENDMENT, dated as of

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of In

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 2, 2024 ☐ TRANSITION REPORT P

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 2, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science Ap

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 4, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I

Amended and Restated Bylaws. Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K as filed with the SEC on September 5, 2024.

Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF SCIENCE APPLICATIONS INTERNATIONAL CORPORATION (a Delaware corporation) As amended, September 4, 2024 TABLE OF CONTENTS Page ARTICLE I 1 SECTION 1.01 REGISTERED OFFICE 1 SECTION 1.02 PRINCIPAL OFFICE 1 SECTION 1.03 OTHER OFFICES 1 ARTICLE II 1 SECTION 2.01 ANNUAL MEETINGS 1 SECTION 2.02 SPECIAL MEETINGS 1 SECTION 2.03 TIME AND PLACE OF MEETINGS 2 SECTION

Three Months Ended August 2, 2024 Percent change August 4, 2023 (in millions, except per share amounts) Revenues $ 1,818 2 % $ 1,784 Operating income 134 (63) % 362 Operating income as a percentage of revenues 7.4 % -1,290 bps 20.3 % Adjusted operati

Exhibit 99.1 SAIC Announces Second Quarter of Fiscal Year 2025 Results •Revenues of $1.82 billion; 2% organic growth •Net income of $81 million; Adjusted EBITDA(1) of $170 million or 9.4% of revenues •Diluted earnings per share of $1.58; Adjusted diluted earnings per share(1) of $2.05 •Cash flows provided by operating activities of $138 million; free cash flow(1) of $241 million •Net bookings of $

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2024 Science Applica

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 5, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I

SAIC Board of Directors Declares Cash Dividend

Exhibit 99.1 August 30, 2024 SAIC Board of Directors Declares Cash Dividend Reston, Va., August 30, 2024 – Science Applications International Corp. (Nasdaq: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on October 25, 2024 to stockholders of record on October 11, 2024. SAIC intends to continue paying di

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inc

t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K

t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35832 A. Full title of plan and the address

Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp

Three Months Ended May 3, 2024 Percent change May 5, 2023 (in millions, except per share amounts) Revenues $ 1,847 (9) % $ 2,028 Operating income 131 (17) % 157 Operating income as a percentage of revenues 7.1 % -60 bps 7.7 % Adjusted operating incom

Exhibit 99.1 SAIC Announces First Quarter of Fiscal Year 2025 Results •Revenues of $1.85 billion; 0.4% organic growth; organic growth reflects impacts of divestitures •Net income of $77 million; Adjusted EBITDA(1) of $166 million or 9.0% of revenues •Diluted earnings per share of $1.48; Adjusted diluted earnings per share(1) of $1.92 •Cash flows provided by operating activities of $98 million; Tra

First Amendment to the Science Applications International Corporation 2023 Equity Incentive Plan, effective March 5, 2024.

Exhibit 10.1 AMENDMENT NO. 1 TO THE SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2023 EQUITY INCENTIVE PLAN WHEREAS, Science Applications International Corporation (the “Company”) maintains the Science Applications International Corporation 2023 Equity Incentive Plan (the “Plan”); and WHEREAS, the Company wishes to amend the Plan to reflect the change in the Company’s listing from the New York S

First Amendment to the Science Applications International Corporation Amended and Restated 2013 Employee Stock Purchase Plan, effective March 5, 2024.

Exhibit 10.2 AMENDMENT NO. 1 TO THE SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2013 EMPLOYEE STOCK PURCHASE PLAN WHEREAS, Science Applications International Corporation (the “Company”) maintains the Science Applications International Corporation 2013 Employee Stock Purchase (the “Plan”) which was amended and restated effective June 7, 2023; and WHEREAS, the Company wishes to amend the Plan to

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 3, 2024 ☐ TRANSITION REPORT PURS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 3, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science Appli

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2024 Science Applications

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp

SAIC Board of Directors Declares Cash Dividend

Exhibit 99.1 May 31, 2024 SAIC Board of Directors Declares Cash Dividend Reston, Va., May 31, 2024 – Science Applications International Corp. (Nasdaq: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on July 26, 2024 to stockholders of record on July 12, 2024. SAIC intends to continue paying dividends on a

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of the Registrant as Specified in Its Charter) Delaware 001- 35832 (State or othe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of the Registrant as Specified in Its Charter) Delaware 001- 35832 (State or other jurisdiction of incorporation) Commission File Number 12010 Sunset Hills Road Reston, Virginia (Address of principal executive offices) 20190 (Zip C

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2023 to December 31, 2023

Exhibit 1.01 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2023 to December 31, 2023 This Conflict Minerals Report (this “Report”) of Science Applications International Corporation (herein referred to as the “Company,” “we,” “us,” or “our”), has been prepared pursuant to Rule 13p-1 (the “Rule”) and Form SD promulgated under the Sec

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Pursuant to § 240.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material Pursuant to § 240.

April 11, 2024 INTRODUCTION Joseph DeNardi Senior Vice President, Investor Relations & Treasurer 3SAIC PROPRIETARY INFORMATION I © SAIC. ALL RIGHTS RESERVED I Asset-light technology integrator with shareholder-focused capital deployment strategy Forw

April 11, 2024 INTRODUCTION Joseph DeNardi Senior Vice President, Investor Relations & Treasurer 3SAIC PROPRIETARY INFORMATION I © SAIC.

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco

Policy Relating to Recovery of Erroneously Awarded Compensation

Exhibit 97 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION RULE 10D-1 COMPENSATION RECOVERY POLICY Effective October 2, 2023 Pursuant to the Listing Standards of the New York Stock Exchange Amended and Restated Effective March 5, 2024 Pursuant to the Listing Standards of The Nasdaq Stock Market LLC Policy The Board of Directors (the “Board”) of Science Applications International Corporation (the “Company”) has adopted this Compensation Recovery Policy (this “Policy”) to comply with Rule 10D-1 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), the Securities and Exchange Commission regulations promulgated thereunder, and applicable listing standards of The Nasdaq Stock Market LLC ("Nasdaq").

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 2, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-35832 Science Applicat

Subsidiaries of Registrant.

Exhibit 21 Subsidiaries of Registrant Jurisdiction of Incorporation or Organization SAIC International Holdings, Inc. Delaware TASC Services Corporation Delaware ATAC Services, LLC Delaware SAIC Gemini Huntsville, LLC Delaware Odyssey Drive I, Ltd. California Valinar, LLC Delaware Halfaker and Associates, LLC Virginia Koverse, Inc. Delaware

Description of Securities.

Exhibit 4.1 Description of Securities General Science Applications International Corporation (“SAIC,” “us,” “we,” or “our”) is currently authorized to issue up to 1,000,000,000 shares of common stock, par value $0.0001 per share and up to 10,000,000 shares of preferred stock, par value $0.0001 per share. Our common stock is registered under Section 12(b) of the Exchange Act. The following summary

PRIOR CURRENT Fiscal Year Fiscal Year 2025 Guidance 2025 Guidance Revenue $7.25B - $7.40B $7.35B - $7.50B Adjusted EBITDA(1) - $680M - $700M Adjusted EBITDA Margin %(1) 9.4% - 9.6% 9.2% - 9.4% Adjusted Diluted EPS(1) $8.00 - $8.20 $8.00 - $8.20 Free

Exhibit 99.1 SAIC Announces Fourth Quarter and Full Fiscal Year 2024 Results •Q4 FY24 revenues of $1.74 billion, 7.7% organic growth(1); FY24 revenues of $7.44 billion, 7.4% organic growth(1); organic growth reflects impacts of divestitures and additional five working days in the prior year •Q4 FY24 net income of $39 million, adjusted EBITDA(1) of $127 million or 7.3% of revenue; FY24 net income o

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco

SAIC Board of Directors Declares Cash Dividend

Exhibit 99.1 March 15, 2024 SAIC Board of Directors Declares Cash Dividend Reston, Va., March 15, 2024 – Science Applications International Corp. (Nasdaq: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on April 26, 2024 to stockholders of record on April 12, 2024. SAIC intends to continue paying dividend

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2024 Science Applicatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco

CERT

Eun Ah Choi Senior Vice President Global Head of Regulatory Operations March 4, 2024 Division of Corporation Finance U.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Science Applications International Corporatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 46-1932921 (State or other jurisdiction of incorporation) (I.R.S. Employer Identific

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-35832 Science Applications

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-35832 Science Applications International Corporation New York Stock Exchange (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed an

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2024 Science Applications International Corporation (Exact name of registrant as specified in charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of incor

SAIC to Host Investor Day in New York City on April 11, 2024 Company also plans to transfer stock market listing to Nasdaq

Exhibit 99.1 February 20, 2024 SAIC to Host Investor Day in New York City on April 11, 2024 Company also plans to transfer stock market listing to Nasdaq Reston, Va., February 20, 2024 – Science Applications International Corp. (NYSE: SAIC) announces that it will hold an Investor Day on Thursday, April 11, 2024 and that the company will transfer its stock exchange listing from the New York Stock E

SAIC / Science Applications International Corporation / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv01884-scienceapplicationsi.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 10)* Name of issuer: Science Applications International Corp Title of Class of Securities: Common Stock CUSIP Number: 808625107 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the a

SAIC / Science Applications International Corporation / Boston Partners - ROBECO INVESTMENT MANAGEMENT INC. Passive Investment

SC 13G/A 1 saica421324.htm ROBECO INVESTMENT MANAGEMENT INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Stat

Sixth Amendment to the Third Amended and Restated Credit Agreement, dated February 8, 2024, by and among SAIC, Citibank N.A., as administrative agent and collateral agent, and certain other lenders and parties thereto. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on February 12, 2024.

Exhibit 10.1 Execution Version SIXTH AMENDMENT This SIXTH AMENDMENT, dated as of February 8, 2024 (this “Agreement”), to the THIRD AMENDED AND RESTATED CREDIT AGREEMENT dated as of October 31, 2018, (as amended by that certain FIRST AMENDMENT, dated as of February 19, 2020, that certain SECOND AMENDMENT, dated as of March 13, 2020, that certain THIRD AMENDMENT, dated as of March 1, 2021, that cert

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2024 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of In

SAIC / Science Applications International Corporation / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5 )* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check th

SAIC / Science Applications International Corporation / BlackRock Inc. Passive Investment

SC 13G/A 1 us8086251076012424.txt us8086251076012424.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 12) SCIENCE APPLICATIONS INTERNATIONAL CORPORATION - (Name of Issuer) Common Stock - (Title of Class of Securities) 808625107 - (CUSIP Number) December 31, 2023 - (Date of Event Which Requires Filing of this Stateme

SAIC to Realign Organization to Optimize Strategic Pivots and Increase Organic Growth

Exhibit 99.1 FOR IMMEDIATE RELEASE December 11, 2023 SAIC to Realign Organization to Optimize Strategic Pivots and Increase Organic Growth HIGHLIGHTS • Five new business groups to replace two current business sectors • New business groups to include Army; Navy; Air Force and Combatant Commands; Space and Intelligence; and Civilian • Realigned organization will seek to reduce hierarchy, increase in

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 11, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of i

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 3, 2023 ☐ TRANSITION REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 3, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science

Three Months Ended November 3, 2023 Percent change October 28, 2022 (in millions, except per share amounts) Revenues $ 1,895 (1) % $ 1,909 Operating income 143 8 % 133 Operating income as a percentage of revenues 7.5 % 50 bps 7.0 % Adjusted operating

Exhibit 99.1 SAIC Announces Third Quarter of Fiscal Year 2024 Results •Revenues of $1.90 billion; 10.6% organic growth adjusted for impact of divestitures •Net income of $93 million; Adjusted EBITDA(1) of $178 million or 9.4% as a % of revenues, an increase of 50 bps year-over-year •Diluted earnings per share of $1.76; Adjusted diluted earnings per share(1) of $2.27 •Cash flows provided by operati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2023 Science Applicat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of In

SAIC Board of Directors Declares Cash Dividend

Exhibit 99.1 December 1, 2023 SAIC Board of Directors Declares Cash Dividend Reston, Va., December 1, 2023 – Science Applications International Corp. (NYSE: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on January 26, 2024 to stockholders of record on January 12, 2024. SAIC intends to continue paying di

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 8, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of i

Three Months Ended August 4, 2023 Percent change July 29, 2022 (in millions, except per share amounts) Revenues $ 1,784 (3) % $ 1,831 Operating income 362 190 % 125 Operating income as a percentage of revenues 20.3 % 1,350 bps 6.8 % Adjusted operatin

Exhibit 99.1 SAIC Announces Second Quarter of Fiscal Year 2024 Results •Revenues of $1.78 billion; 8.3% organic growth adjusted for impact of divestitures •Net income of $247 million; Adjusted EBITDA(1) of $174 million or 9.8% as a % of revenues, an increase of 70 bps year-over-year •Diluted earnings per share of $4.56; Adjusted diluted earnings per share(1) of $2.05 •Cash flows provided by operat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 4, 2023 ☐ TRANSITION REPORT P

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 4, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science Ap

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 7, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I

Calculation of Filing Fee Table.

EX-FILING FEES Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Science Applications International Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price (2) Fee Rate Amount of

As filed with the Securities and Exchange Commission on June 29, 2023

S-8 POS As filed with the Securities and Exchange Commission on June 29, 2023 Registration No.

t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K

t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35832 A. Full title of plan and the address

As filed with the Securities and Exchange Commission on June 29, 2023

S-8 As filed with the Securities and Exchange Commission on June 29, 2023 Registration No.

Form of Performance Stock Unit Award Agreement of the Science Applications International Corporation 2023 Equity Incentive Plan. Incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed with the SEC on June 13, 2023.

Exhibit 10.3 FORM PSU AGREEMENT SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2023 EQUITY INCENTIVE PLAN FY – FY PERFORMANCE STOCK UNIT AWARD AGREEMENT BY ACCEPTING THE AWARD DESCRIBED IN THIS AGREEMENT, RECIPIENT VOLUNTARILY AGREES TO ALL OF THE TERMS AND CONDITIONS SET FORTH IN THE 2023 EQUITY INCENTIVE PLAN AND THIS AGREEMENT. This Award for Performance Stock Units (PSUs) is granted pursuant t

Science Applications International Corporation Amended and Restated 2013 Employee Stock Purchase Plan, effective June 7, 2023. Incorporated by reference to Exhibit 10.4 to the Company's Current Report on Form 8-K filed with the SEC on June 13, 2023.

Exhibit 10.4 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2013 EMPLOYEE STOCK PURCHASE PLAN 1.Amendment and Restatement of Plan. Science Applications International Corporation (the “Company”) restates and amends the Science Applications International Corporation 2013 Employee Stock Purchase Plan (the “Plan”), effective June 7, 2023, to continue to grant options for purchase of Shares as determin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2023 Science Applications

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp

Form of Restricted Stock Unit Award Agreement of the Science Applications International Corporation 2023 Equity Incentive Plan. Incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the SEC on June 13, 2023.

Exhibit 10.2 FORM RSU AGREEMENT SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2023 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT BY ACCEPTING THE AWARD DESCRIBED IN THIS AGREEMENT, RECIPIENT VOLUNTARILY AGREES TO ALL OF THE TERMS AND CONDITIONS SET FORTH IN THE 2023 EQUITY INCENTIVE PLAN AND THIS AGREEMENT. This Award for Restricted Stock Units (RSUs) is granted pursuant to the term

As filed with the Securities and Exchange Commission on June 7, 2023

S-8 As filed with the Securities and Exchange Commission on June 7, 2023 Registration No.

Science Applications International Corporation 2023 Equity Incentive Plan, effective June 7, 2023. Incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form S-8 (File No. 333-272484) as filed with the Securities and Exchange Commission (SEC) on June 7, 2023.

EX-4.3 Exhibit 4.3 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2023 EQUITY INCENTIVE PLAN (1) Purpose of the Plan. The purpose of this 2023 Equity Incentive Plan is to enhance the long-term stockholder value of Science Applications International Corporation and its affiliated companies by offering opportunities to eligible individuals to participate in the growth in value of the equity of Scien

Calculation of Filing Fee Table.

EX-FILING FEES Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Science Applications International Corporation (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price (2) Fee Rate Amount of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2023 Science Applications

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp

Three Months Ended May 5, 2023 Percent change April 29, 2022 (in millions, except per share amounts) Revenues $ 2,028 2 % $ 1,996 Operating income 157 26 % 125 Operating income as a percentage of revenues 7.7 % 140 bps 6.3 % Adjusted operating income

Exhibit 99.1 SAIC Announces First Quarter of Fiscal Year 2024 Results •Revenues of $2.03 billion; 2% revenue growth, 3.5% growth adjusted for impact of deconsolidation of Forfeiture Support Associates joint venture •Net income of $98 million; Adjusted EBITDA(1) of $189 million or 9.3% as a % of revenues •Diluted earnings per share: $1.79; Adjusted diluted earnings per share(1): $2.14 •Net bookings

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 5, 2023 ☐ TRANSITION REPORT PURS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 5, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-35832 Science Appli

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp

SAIC Board of Directors Declares Cash Dividend

Exhibit 99.1 June 2, 2023 SAIC Board of Directors Declares Cash Dividend Reston, Va., June 2, 2023 – Science Applications International Corp. (NYSE: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on July 28, 2023 to stockholders of record on July 14, 2023. SAIC intends to continue paying dividends on a q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001- 35832 (State or other ju

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001- 35832 (State or other jurisdiction of incorporation) Commission File Number 12010 Sunset Hills Road Reston, Virginia (Address of principal executive offices) 20190 (Zip Code)

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2022 to December 31, 2022

Exhibit 1.01 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2022 to December 31, 2022 This Conflict Minerals Report (this “Report”) of Science Applications International Corporation (herein referred to as the “Company,” “we,” “us,” or “our”), has been prepared pursuant to Rule 13p-1 (the “Rule”) and Form SD promulgated under the Sec

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2023 Science Applications

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of incorp

Transition Letter, dated May 15, 2023. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on May 18, 2023.

EX-10.1 Exhibit 10.1 12010 Sunset Hills Rd, Reston, VA 20190 703.676.4300 | saic.com May 15, 2023 To: Nazzic S. Keene, Chief Executive Officer From: Donna S. Morea, Chair of the Board of Directors RE: Transition and Retirement As we have discussed, we understand your desire to retire from your role as Chief Executive Officer (CEO) and a member of the Board of Directors of SAIC, effective October 2

SAIC Announces CEO Transition Toni Townes-Whitley to become CEO and join SAIC’s Board Nazzic Keene to retire from SAIC following transition period

EX-99.1 Exhibit 99.1 SAIC Announces CEO Transition Toni Townes-Whitley to become CEO and join SAIC’s Board Nazzic Keene to retire from SAIC following transition period RESTON, Va.— (BUSINESS WIRE) — Science Applications International Corp. (NYSE: SAIC) today announced the appointment of 35-year global technology veteran Toni Townes-Whitley as the company’s Chief Executive Officer, effective Octobe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 2)

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorpo

May 8, 2023

Exhibit 99.1 May 8, 2023 SAIC Completes $350 Million Sale of Its Logistics and Supply Chain Management Business to ASRC Federal Reston, Va., May 8, 2023 – Science Applications International Corp. (NYSE: SAIC) announced today that it has completed the sale of its Logistics and Supply Chain Management Business to ASRC Federal for $350 million. The divestiture is consistent with SAIC’s broader strate

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

Schedule 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Pursuant to § 240.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material Pursuant to § 240.

ARS

FY23 ANNUAL REPORT 1 S&P 500 INDEX TOTAL SHAREHOLDER RETURN FOR FISCAL YEAR 2023 5% DEAR FELLOW SHAREHOLDERS, Fiscal year 2023 was a year of great accomplishment and significant progress for SAIC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2023 Science Applicatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco

April 11, 2023 Introduction Joseph DeNardi Vice President, Investor Relations and Strategic Ventures 3SAIC PROPRIETARY INFORMATION I © SAIC. ALL RIGHTS RESERVED IAsset-light technology integrator with shareholder-focused capital deployment strategy C

saic2023investorday April 11, 2023 Introduction Joseph DeNardi Vice President, Investor Relations and Strategic Ventures 3SAIC PROPRIETARY INFORMATION I © SAIC.

Subsidiaries of Registrant.

Exhibit 21 Subsidiaries of Registrant Jurisdiction of Incorporation or Organization SAIC International Holdings, Inc. Delaware SAIC Gemini Huntsville, LLC Delaware Odyssey Drive I, Ltd. California Valinar, LLC Delaware Forfeiture Support Associates, LLC Delaware Halfaker and Associates, LLC Virginia

Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended February 3, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-35832 Science Applicat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2023 Science Application

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 3, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incor

PRIOR Estimated Impacts Estimated Impacts CURRENT Fiscal Year from L&SCM sale, from Operating Fiscal Year 2024 Guidance FSA, and Section 174 Performance 2024 Guidance Revenue $7.6B - $7.8B Less $650M(2) Plus $50M - $100M $7.05B - $7.20B Adjusted EBIT

Exhibit 99.1 SAIC Announces Fourth Quarter and Full Fiscal Year 2023 Results •Q4 of fiscal year 2023 revenues of $1.97 billion, 10% growth over Q4 of fiscal year 2022; fiscal year 2023 revenues of $7.70 billion, 4% growth over fiscal year 2022 •Q4 of fiscal year 2023 diluted earnings per share of $1.34; Adjusted diluted earnings per share(1) of $2.04 •Reported fiscal year 2023 cash flows provided

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2023 Science Applicatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2023 Science Applicatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco

Amended and Restated Bylaws. Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K as filed with the Commission on March 29, 2023.

Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF SCIENCE APPLICATIONS INTERNATIONAL CORPORATION (a Delaware corporation) As amended, March 29, 2023 TABLE OF CONTENTS Page ARTICLE I 1 SECTION 1.01 REGISTERED OFFICE 1 SECTION 1.02 PRINCIPAL OFFICE 1 SECTION 1.03 OTHER OFFICES 1 ARTICLE II 1 SECTION 2.01 ANNUAL MEETINGS 1 SECTION 2.02 SPECIAL MEETINGS 1 SECTION 2.03 TIME AND PLACE OF MEETINGS 2 SECTION 2.0

SAIC Board of Directors Declares Cash Dividend

Exhibit 99.1 March 29, 2023 SAIC Board of Directors Declares Cash Dividend Reston, Va., March 29, 2023 – Science Applications International Corp. (NYSE: SAIC) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on April 28, 2023 to stockholders of record on April 14, 2023. SAIC intends to continue paying dividends

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2023 Science Applicatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco

March 23, 2023

Exhibit 99.1 March 23, 2023 SAIC Signs Definitive Agreement to Sell Its Logistics and Supply Chain Management Business to ASRC Federal for $350 Million Reston, Va., March 23, 2023 – Science Applications International Corp. (NYSE: SAIC) announced today that it has signed a definitive agreement to sell its logistics and supply chain management business to ASRC Federal Holding Company, LLC (“ASRC Fed

SAIC / Science Applications International Corp / Boston Partners - ROBECO INVESTMENT MANAGEMENT INC. Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua

SAIC / Science Applications International Corp / BlackRock Inc. Passive Investment

SC 13G/A 1 us8086251076021023.txt us8086251076021023.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 11) SCIENCE APPLICATIONS INTERNATIONAL CORPORATION - (Name of Issuer) Common Stock - (Title of Class of Securities) 808625107 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Stateme

SAIC / Science Applications International Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv01852-scienceapplicationsi.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 9)* Name of issuer: Science Applications International Corp. Title of Class of Securities: Common Stock CUSIP Number: 808625107 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the a

SAIC / Science Applications International Corp / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check th

SAIC / Science Applications International Corp / BlackRock Inc. Passive Investment

SC 13G/A 1 us8086251076012723.txt us8086251076012423.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 10) SCIENCE APPLICATIONS INTERNATIONAL CORPORATION - (Name of Issuer) Common Stock - (Title of Class of Securities) 808625107 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Stateme

SAIC / Science Applications International Corp / BlackRock Inc. Passive Investment

us8086251076012423.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 10) SCIENCE APPLICATIONS INTERNATIONAL CORPORATION - (Name of Issuer) Common Stock - (Title of Class of Securities) 808625107 - (CUSIP Number) December 31, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to d

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2023 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of inc

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of in

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 28, 2022 ☐ TRANSITION REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 28, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Regi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2022 Science Applicat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of In

Three Months Ended Nine Months Ended October 28, 2022 Percent change October 29, 2021 October 28, 2022 Percent change October 29, 2021 (in millions, except per share amounts) Revenues $ 1,909 1 % $ 1,898 $ 5,736 2 % $ 5,612 Operating income 133 17 %

Exhibit 99.1 SAIC Announces Third Quarter of Fiscal Year 2023 Results •Net bookings of $2.0 billion resulting in a book-to-bill of 1.1x in the quarter •Revenues of $1.91 billion; 1% revenue growth •Diluted earnings per share: $1.45; Adjusted diluted earnings per share(1): $1.90 •Company increases revenue and adjusted diluted EPS(1) guidance for fiscal year 2023 RESTON, VA, December 5, 2022—Science

SAIC BOARD OF DIRECTORS DECLARES CASH DIVIDEND

Exhibit 99.1 FOR IMMEDIATE RELEASE November 30, 2022 SAIC BOARD OF DIRECTORS DECLARES CASH DIVIDEND Reston, Va., November 30, 2022 ? Science Applications International Corp. (NYSE: SAIC) announced today that the company?s board of directors declared a cash dividend of $0.37 per share of the company?s common stock payable on January 27, 2023 to stockholders of record on January 13, 2023. SAIC inten

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 29, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 1, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 29, 2022 ☐ TRANSITION REPORT PU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 29, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Registr

Three Months Ended Six Months Ended July 29, 2022 Percent change July 30, 2021 July 29, 2022 Percent change July 30, 2021 (in millions, except per share amounts) Revenues $ 1,831 — % $ 1,836 $ 3,827 3 % $ 3,714 Operating income 125 (6) % 133 250 (5)

Exhibit 99.1 SAIC Announces Second Quarter of Fiscal Year 2023 Results ?Net bookings of $2.1 billion resulting in a book-to-bill of 1.1x in the quarter and 1.0x TTM ?Revenues of $1.83 billion, approximately flat with prior year ?Diluted earnings per share: $1.30; Adjusted diluted earnings per share(1): $1.75 ?Company increases revenue and adjusted diluted EPS(1) guidance for fiscal year 2023 RESTO

SAIC BOARD OF DIRECTORS DECLARES CASH DIVIDEND

Exhibit 99.1 FOR IMMEDIATE RELEASE August 30, 2022 SAIC BOARD OF DIRECTORS DECLARES CASH DIVIDEND Reston, Va., August 30, 2022 ? Science Applications International Corp. (NYSE: SAIC) announced today that the company?s board of directors declared a cash dividend of $0.37 per share of the company?s common stock payable on October 28, 2022 to stockholders of record on October 14, 2022. SAIC intends t

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 30, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inc

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incor

Fifth Amendment to the Third Amended and Restated Credit Agreement, dated June 30, 2022, by and among SAIC, Citibank N.A., as administrative agent and collateral agent, and certain other lenders and parties thereto. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on June 30, 2022.

Exhibit 10.1 EXECUTION VERSION FIFTH AMENDMENT This FIFTH AMENDMENT, dated as of June 30, 2022 (this ?Agreement?), to the THIRD AMENDED AND RESTATED CREDIT AGREEMENT dated as of October 31, 2018, (as amended by that certain FIRST AMENDMENT, dated as of February 19, 2020, that certain SECOND AMENDMENT, dated as of March 13, 2020, that certain THIRD AMENDMENT, dated as of March 1, 2021 and that cert

SAIC Appoints Hilary L. Hageman as Executive Vice President, General Counsel, and Corporate Secretary

Exhibit 99.1 SAIC Appoints Hilary L. Hageman as Executive Vice President, General Counsel, and Corporate Secretary RESTON, Va.?(BUSINESS WIRE)? Science Applications International Corp. (NYSE: SAIC) today announces the appointment of Hilary L. Hageman as Executive Vice President, General Counsel, and Corporate Secretary, effective July 11, 2022. Steven G. Mahon, SAIC?s Executive Vice President, Gen

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of incor

t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K

t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35832 A. Full title of plan and the address

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incor

FIFTH AMENDMENT

Exhibit 99.1 FIFTH AMENDMENT This FIFTH AMENDMENT, dated as of June [30], 2022 (this ?Agreement?), to the THIRD AMENDED AND RESTATED CREDIT AGREEMENT dated as of October 31, 2018, (as amended by that certain FIRST AMENDMENT, dated as of February 19, 2020, that certain SECOND AMENDMENT, dated as of March 13, 2020, that certain THIRD AMENDMENT, dated as of March 1, 2021 and that certain FOURTH AMEND

Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 29, 2022 ☐ TRANSITION REPORT P

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 29, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Regist

Three Months Ended April 29, 2022 Percent change April 30, 2021 (in millions, except per share amounts) Revenues $ 1,996 6 % $ 1,878 Operating income 125 (4) % 130 Operating income as a percentage of revenues 6.3 % -60 bps 6.9 % Adjusted operating in

Exhibit 99.1 SAIC Announces First Quarter of Fiscal Year 2023 Results ?Revenues increase to $2.0 billion; 6% total revenue growth, approximately 4% growth excluding acquired revenues ?Diluted earnings per share: $1.29; Adjusted diluted earnings per share(1): $1.88 ?Company increases revenue and adjusted diluted EPS(1) guidance for fiscal year 2023 ?Board authorizes share repurchase program up to 8

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp

SAIC BOARD OF DIRECTORS DECLARES CASH DIVIDEND

Exhibit 99.1 FOR IMMEDIATE RELEASE May 31, 2022 SAIC BOARD OF DIRECTORS DECLARES CASH DIVIDEND Reston, Va., May 31, 2022 ? Science Applications International Corp. (NYSE: SAIC) announced today that the company?s board of directors declared a cash dividend of $0.37 per share of the company?s common stock payable on July 29, 2022 to stockholders of record on July 15, 2022. SAIC intends to continue p

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2021 to December 31, 2021

Exhibit 1.01 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2021 to December 31, 2021 This Conflict Minerals Report (this ?Report?) of Science Applications International Corporation (herein referred to as the ?Company,? ?we,? ?us,? or ?our?), has been prepared pursuant to Rule 13p-1 (the ?Rule?) and Form SD promulgated under the Sec

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001- 35832 46-1932921 (State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001- 35832 46-1932921 (State or other jurisdiction of incorporation or organization) Commission File Number (I.R.S. Employer Identification No.) 12010 Sunset Hills Road Reston, Vi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy Statement x Definitive Additional Materials ? Soliciting Material Pursuant to ? 240.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

DEF 14A 1 saic2022proxy.htm DEFINITIVE PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as pe

SAIC / Science Applications International Corp / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) March 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant

Form of Restricted Stock Unit Award Agreement of the Science Applications International Corporation 2013 Amended and Restated Equity Incentive Plan. Incorporated by reference to Exhibit 10.21 to the Company’s Annual Report on Form 10-K as filed with the SEC on March 28, 2022.

Exhibit 10.21 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2013 AMENDED AND RESTATED EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT BY ACCEPTING THIS AWARD, YOU VOLUNTARILY AGREE TO ALL OF THE TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT AND IN THE PLAN. Science Applications International Corporation, a Delaware corporation (the ?Company?), hereby grants to the participant named

Fiscal Year 2023 Guidance Revenue $7.35 billion to $7.55 billion Adjusted EBITDA Margin(1) Approximately 8.9% Adjusted Diluted EPS(1) $6.80 to $7.10 Free Cash Flow(1) $500 million to $530 million

Exhibit 99.1 SAIC Announces Fourth Quarter and Full Fiscal Year 2022 Results ?Q4 revenues of $1.8 billion, 4% growth; FY22 revenues of $7.4 billion, 5% growth ?Q4 adjusted EBITDA(1) as a % of revenues of 8.2%; 9.3% for fiscal year 2022 ?Q4 diluted earnings per share: $0.76; adjusted diluted earnings per share(1): $1.50 ?Book to bill of 1.2 for the fourth quarter; 1.3 for fiscal year 2022; backlog

Form of Performance Share Award Agreement of the Science Applications International Corporation 2013 Amended and Restated Equity Incentive Plan. Incorporated by reference to Exhibit 10.22 to the Company’s Annual Report on Form 10-K as filed with the SEC on March 28, 2022.

Exhibit 10.22 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION 2013 AMENDED AND RESTATED EQUITY INCENTIVE PLAN PERFORMANCE SHARE AWARD AGREEMENT BY ACCEPTING THE AWARD DESCRIBED IN THIS AGREEMENT, YOU VOLUNTARILY AGREE TO ALL OF THE TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT, THE AWARD GRANT NOTICE AND IN THE PLAN. This Performance Share Award Agreement (this ?Agreement?), effective as of the

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 28, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Registrant a

Subsidiaries of Registrant.

Exhibit 21 Subsidiaries of Registrant Jurisdiction of Incorporation or Organization SAIC International Holdings, Inc. Delaware SAIC Gemini Huntsville, LLC Delaware Odyssey Drive I, Ltd. California Valinar, LLC Delaware Forfeiture Support Associates, LLC Delaware Halfaker and Associates, LLC Virginia

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 28, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco

SAIC BOARD OF DIRECTORS DECLARES CASH DIVIDEND

Exhibit 99.1 FOR IMMEDIATE RELEASE March 23, 2022 SAIC BOARD OF DIRECTORS DECLARES CASH DIVIDEND Reston, Va., March 23, 2022 ? Science Applications International Corp. (NYSE: SAIC) announced today that the company?s board of directors declared a cash dividend of $0.37 per share of the company?s common stock payable on April 29, 2022 to stockholders of record on April 14, 2022. SAIC intends to cont

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2022 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco

SAIC / Science Applications International Corp / Boston Partners - ROBECO INVESTMENT MANAGEMENT INC. Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua

SAIC / Science Applications International Corp / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: Science Applications International Corp. Title of Class of Securities: Common Stock CUSIP Number: 808625107 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this

SAIC / Science Applications International Corp / BlackRock Inc. Passive Investment

us8086251076020722.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 9) SCIENCE APPLICATIONS INTERNATIONAL CORPORATION - (Name of Issuer) Common Stock - (Title of Class of Securities) 808625107 - (CUSIP Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to de

SAIC / Science Applications International Corp / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Science Applications International Corp (Name of Issuer) Common Stock (Title of Class of Securities) 808625107 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursu

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of In

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 29, 2021 ☐ TRANSITION REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 29, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Regi

Three Months Ended Nine Months Ended October 29, 2021 Percent change October 30, 2020 October 29, 2021 Percent change October 30, 2020 (in millions, except per share amounts) Revenues $ 1,898 4 % $ 1,818 $ 5,612 5 % $ 5,339 Operating income 114 4 % 1

Exhibit 99.1 SAIC Announces Third Quarter of Fiscal Year 2022 Results ?Revenues increase to $1.9 billion; 4.4% total revenue growth, 2.1% growth excluding acquired revenues ?Diluted earnings per share increase to $1.22; Adjusted diluted earnings per share(1) increase to $1.85 ?Company raises revenue, adjusted EBITDA margin(1), adjusted diluted EPS(1), and free cash flow(1) guidance for fiscal year

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 30, 2021 ☐ TRANSITION REPORT PU

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Registr

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of I

Three Months Ended Six Months Ended July 30, 2021 Percent change July 31, 2020 July 30, 2021 Percent change July 31, 2020 (in millions, except per share amounts) Revenues $ 1,836 4 % $ 1,764 $ 3,714 5 % $ 3,521 Operating income 133 33 % 100 263 48 %

Exhibit 99.1 SAIC Announces Second Quarter of Fiscal Year 2022 Results ?Revenues increase to $1.8 billion; 4.1% total revenue growth, 3.8% growth excluding acquired revenues ?Diluted earnings per share increase to $1.41; Adjusted diluted earnings per share(1) increase to $1.97 ?Net bookings of $1.6 billion; Book-to-bill ratio of 0.9 for the second quarter ?Company raises revenue, adjusted EBITDA m

Fourth Amendment to the Third Amended and Restated Credit Agreement, dated July 2, 2021, by and among SAIC, Citibank N.A., as administrative agent and collateral agent, and certain other lenders and parties thereto. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on July 7, 2021.

Exhibit 10.1 Execution Version FOURTH AMENDMENT This FOURTH AMENDMENT, dated as of July 2, 2021 (this ?Agreement?), to the THIRD AMENDED AND RESTATED CREDIT AGREEMENT dated as of October 31, 2018, (as amended by that certain FIRST AMENDMENT, dated as of February 19, 2020, that certain SECOND AMENDMENT, dated as of March 13, 2020, and that certain THIRD AMENDMENT, dated as of March 1, 2021 and as o

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 29, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of incor

JUNE 29, 2021

Exhibit 99.1 FOR IMMEDIATE RELEASE JUNE 29, 2021 SAIC APPOINTS NEW BOARD MEMBER MILFORD MCGUIRT New SAIC board member brings decades of public accounting and auditing experience and years of overseeing exceptional client service delivery Reston, Va., JUNE 29, 2021 ? Science Applications International Corp. (NYSE: SAIC) today announced the appointment of Milford W. McGuirt, retired managing partner

t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K

t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 11-K x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ¨ TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35832 A. Full title of plan and the address

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of incorp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2021 ☐ TRANSITION REPORT P

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Regist

Three Months Ended April 30, 2021 Percent change May 1, 2020 (in millions, except per share amounts) Revenues $ 1,878 7 % $ 1,757 Operating income 130 67 % 78 Operating income as a percentage of revenues 6.9 % 250 bps 4.4 % Adjusted operating income(

Exhibit 99.1 SAIC Announces First Quarter of Fiscal Year 2022 Results ?Revenues increase to $1.9 billion; ~7% total revenue growth, 2.6% growth excluding acquired revenues ?Diluted earnings per share increase to $1.38; Adjusted diluted earnings per share(1) increase to $1.94 ?Net bookings of $4.2 billion; Book-to-bill ratio of 2.2 for the first quarter ?Company increases lower end of revenue and a

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incorp

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2020 to December 31, 2020

Exhibit 1.01 SCIENCE APPLICATIONS INTERNATIONAL CORPORATION CONFLICT MINERALS REPORT For the reporting period from January 1, 2020 to December 31, 2020 This Conflict Minerals Report (this ?Report?) of Science Applications International Corporation (herein referred to as the ?Company,? ?we,? ?us,? or ?our?), has been prepared pursuant to Rule 13p-1 (the ?Rule?) and Form SD promulgated under the Sec

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001- 35832 46-1932921 (State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED DISCLOSURE REPORT Science Applications International Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 001- 35832 46-1932921 (State or other jurisdiction of incorporation or organization) Commission File Number (I.R.S. Employer Identification No.) 12010 Sunset Hills Road Reston, Vi

- DEFINITIVE PROXY STATEMENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ? Definitive Additional Materials ? Soliciting Material Pursuant to ? 240.

- DEFA14A

DEFA14A 1 saic2021addlproxy.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule

Annual Report - 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended January 29, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number Exact Name of Registrant a

Subsidiaries of Registrant.

Exhibit 21 Subsidiaries of Registrant Jurisdiction of Incorporation or Organization SAIC International Holdings, Inc. Delaware SAIC Gemini Huntsville, LLC Delaware Odyssey Drive I, Ltd. California Valinar, LLC Delaware Engility Services, LLC Delaware Engility LLC Delaware Forfeiture Support Associates, LLC Delaware

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Inco

Fiscal Year 2022 Guidance Revenue $7.1 billion to $7.3 billion Adjusted EBITDA Margin(1) 8.6% to 8.8% Adjusted Diluted EPS(1) $6.00 to $6.25 Free Cash Flow(1) $430 million to $470 million

Exhibit 99.1 SAIC Announces Fourth Quarter and Full Fiscal Year 2021 Results Q4 Revenues of $1.7 billion; 11 percent growth Q4 Diluted earnings per share: $1.05; adjusted diluted earnings per share(1): $1.67 Q4 Adjusted EBITDA(1) as a % of revenues of 9.3%; 8.9% for fiscal year 2021 Book to bill of 0.4 for the fourth quarter; 1.7 for fiscal year 2021 Share repurchases re-initiated during the fourt

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other jurisdiction of inco

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 1, 2021 Science Applications International Corporation (Exact name of registrant as specified in its charter) Delaware 001-35832 46-1932921 (State or other Jurisdiction of Incor

Third Amendment to the Third Amended and Restated Credit Agreement, dated March 1, 2021, by and among SAIC, Citibank N.A., as administrative agent and collateral agent, and certain other lenders and parties thereto. Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on March 5, 2021.

Exhibit 10.1 Execution Version THIRD AMENDMENT This THIRD AMENDMENT, dated as of March 1, 2021 (this ?Agreement?), to the THIRD AMENDED AND RESTATED CREDIT AGREEMENT dated as of October 31, 2018 (as amended by the FIRST AMENDMENT, dated as of February 19, 2020, as further amended by the SECOND AMENDMENT, dated as of March 13, 2020, and as otherwise amended from time to time prior to the date hereo

-

CORRESP 1 filename1.htm Prabu Natarajan Chief Financial Officer Science Applications International Corporation 12010 Sunset Hills Road Reston, VA 20190 February 16, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street NE Washington, D.C. 20549 Attn: Kathryn Jacobson Robert Littlepage RE: Science Applications International